These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 7026245

  • 1. Serial electrophysiological testing of antiarrhythmic drug efficacy in patients with recurrent ventricular tachycardia.
    Breithardt G, Seipel L, Abendroth RR, Loogen F.
    Eur Heart J; 1980 Feb; 1(1):11-24. PubMed ID: 7026245
    [No Abstract] [Full Text] [Related]

  • 2. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD, Kay HR, Horowitz LN, Spielman SR, Greenspan AM, Kutalek SP.
    Am J Cardiol; 1988 May 01; 61(13):1050-5. PubMed ID: 3284319
    [Abstract] [Full Text] [Related]

  • 3. Clinical electrophysiology of ventricular tachycardia.
    Prystowsky EN, Heger JJ, Lloyd EA, Zipes DP.
    Cardiol Clin; 1983 May 01; 1(2):253-73. PubMed ID: 6544638
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP, Spielman SR, Kutalek SP, Kay HR, Horowitz LN.
    Am J Cardiol; 1987 Feb 01; 59(4):291-5. PubMed ID: 3544793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Kasanuki H, Ohnishi S, Hirosawa K.
    Jpn Circ J; 1983 Jan 01; 47(1):105-23. PubMed ID: 6827769
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia.
    Breithardt G, Seipel L, Abendroth RR.
    J Cardiovasc Pharmacol; 1981 Jan 01; 3(5):1026-37. PubMed ID: 6168848
    [Abstract] [Full Text] [Related]

  • 10. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG, McGovern B, Schoenfeld MH, Garan H, Newell JB, McElroy M, Ruskin JN.
    Am Heart J; 1988 Feb 01; 115(2):360-6. PubMed ID: 3341170
    [Abstract] [Full Text] [Related]

  • 11. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F, Santarelli P, Montenero S, Nobile A, Spampinato A, Nava S, Zecchi P, Manzoli U.
    Cardiologia; 1988 Apr 01; 33(4):399-405. PubMed ID: 3409264
    [No Abstract] [Full Text] [Related]

  • 12. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S, Sawanobori T, Tamura K, Kane KA, Parratt JR.
    Jpn J Pharmacol; 1994 Jul 01; 65(3):193-200. PubMed ID: 7799519
    [Abstract] [Full Text] [Related]

  • 13. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE, Werner JA, Bardy GH, Graham EL, Pulaski WP, Fahrenbruch CE, Greene HL.
    Am Heart J; 1986 Aug 01; 112(2):322-6. PubMed ID: 3739884
    [Abstract] [Full Text] [Related]

  • 14. Treatment of recurrent sustained ventricular tachycardia with mexiletine and disopyramide. Control by programmed ventricular stimulation.
    Manz M, Steinbeck G, Nitsch J, Lüderitz B.
    Br Heart J; 1983 Mar 01; 49(3):222-8. PubMed ID: 6830659
    [Abstract] [Full Text] [Related]

  • 15. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias.
    Hohnloser SH, Raeder EA, Podrid PJ, Graboys TB, Lown B.
    Am Heart J; 1987 Jul 01; 114(1 Pt 1):1-7. PubMed ID: 3604854
    [Abstract] [Full Text] [Related]

  • 16. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
    Mendoza I, Moleiro F, Castellanos A, Casal H, Arends E, Medina V.
    Arch Inst Cardiol Mex; 1982 Jul 01; 52(4):301-11. PubMed ID: 7138133
    [Abstract] [Full Text] [Related]

  • 17. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of class IA antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG, Seiden SW, Matos JA, Waspe LE, Fisher JD.
    J Am Coll Cardiol; 1985 Sep 01; 6(3):539-44. PubMed ID: 2411776
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ, Easley AR, Mann DE.
    Am J Cardiol; 1987 Jun 01; 59(15):1319-24. PubMed ID: 3109228
    [Abstract] [Full Text] [Related]

  • 19. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH, McGovern B, Garan H, Kelly E, Grant G, Ruskin JN.
    J Am Coll Cardiol; 1985 Aug 01; 6(2):298-306. PubMed ID: 4019918
    [Abstract] [Full Text] [Related]

  • 20. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ, Roden D, Primm RK, Oates JA, Woosley RL.
    Circulation; 1983 May 01; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.